Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Department of Genetics and Cell Biology, Basic Medical College, Qingdao University, Qingdao, China.
Front Immunol. 2024 Feb 22;15:1264856. doi: 10.3389/fimmu.2024.1264856. eCollection 2024.
Increasing evidence indicating that coronavirus disease 2019 (COVID-19) increased the incidence and related risks of pericarditis and whether COVID-19 vaccine is related to pericarditis has triggered research and discussion. However, mechanisms behind the link between COVID-19 and pericarditis are still unknown. The objective of this study was to further elucidate the molecular mechanisms of COVID-19 with pericarditis at the gene level using bioinformatics analysis.
Genes associated with COVID-19 and pericarditis were collected from databases using limited screening criteria and intersected to identify the common genes of COVID-19 and pericarditis. Subsequently, gene ontology, pathway enrichment, protein-protein interaction, and immune infiltration analyses were conducted. Finally, TF-gene, gene-miRNA, gene-disease, protein-chemical, and protein-drug interaction networks were constructed based on hub gene identification.
A total of 313 common genes were selected, and enrichment analyses were performed to determine their biological functions and signaling pathways. Eight hub genes (, , , , , , , and ) were identified using the protein-protein interaction network, and immune infiltration analysis was then carried out to examine the functional relationship between the eight hub genes and immune cells as well as changes in immune cells in disease. Transcription factors, miRNAs, diseases, chemicals, and drugs with high correlation with hub genes were predicted using bioinformatics analysis.
This study revealed a common gene interaction network between COVID-19 and pericarditis. The screened functional pathways, hub genes, potential compounds, and drugs provided new insights for further research on COVID-19 associated with pericarditis.
越来越多的证据表明,2019 年冠状病毒病(COVID-19)增加了心包炎的发病率和相关风险,COVID-19 疫苗是否与心包炎有关,这引发了研究和讨论。然而,COVID-19 与心包炎之间的联系机制尚不清楚。本研究旨在通过生物信息学分析,从基因水平上进一步阐明 COVID-19 合并心包炎的分子机制。
使用有限的筛选标准从数据库中收集与 COVID-19 和心包炎相关的基因,并进行交集以确定 COVID-19 和心包炎的共同基因。随后进行基因本体、通路富集、蛋白质-蛋白质相互作用和免疫浸润分析。最后,基于枢纽基因鉴定构建 TF-基因、基因-miRNA、基因-疾病、蛋白质-化学物质和蛋白质-药物相互作用网络。
共筛选出 313 个共同基因,进行富集分析以确定其生物学功能和信号通路。利用蛋白质-蛋白质相互作用网络鉴定出 8 个枢纽基因(、、、、、、和),然后进行免疫浸润分析,以研究这 8 个枢纽基因与免疫细胞以及疾病中免疫细胞变化之间的功能关系。利用生物信息学分析预测与枢纽基因具有高相关性的转录因子、miRNA、疾病、化学物质和药物。
本研究揭示了 COVID-19 与心包炎之间共同的基因相互作用网络。筛选出的功能通路、枢纽基因、潜在化合物和药物为进一步研究 COVID-19 相关心包炎提供了新的思路。